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ABSTRACT
Tobeeffective,antisensemoleculesshouldbestable
inbiologicalfluids,non-toxic,formstableandspecific
duplexes with target RNAs and readily penetrate
through cell membranes without non-specific effects
on cell function. We report herein that negatively
charged DNA mimics representing chiral analogues
of peptide nucleic acids with a constrained trans-
4-hydroxy-N-acetylpyrrolidine-2-phosphonate back-
bone (pHypNAs) meet these criteria. To demonstrate
this, we compared silencing potency of these
compounds with that of previously evaluated as effi-
cient gene knockdown molecules hetero-oligomers
consistingofalternatingphosphono-PNA monomers
and PNA-like monomers based on trans-4-hydroxy-
L-proline (HypNA-pPNAs). Antisense potential of
pHypNA mimics was confirmed in a cell-free transla-
tion assay with firefly luciferase as well as in a living
cell assay with green fluorescent protein. In both
cases, the pHypNA antisense oligomers provided a
specific knockdown of a target protein production.
Confocal microscopy showed that pHypNAs, when
transfected into living cells, demonstrated efficient
cellular uptake with distribution in the cytosol and
nucleus. Also, the high potency of pHypNAs for
down-regulation of Ras-like GTPase Ras-dva in
Xenopus embryos was demonstrated in comparison
with phosphorodiamidate morpholino oligomers.
Therefore, our data suggest that pHypNAs are novel
antisense agents with potential widespread in vitro
and in vivo applications in basic research involving
live cells and intact organisms.
INTRODUCTION
Over the last years, antisense approaches to the speciﬁc in vivo
suppression of gene expression received an increased atten-
tion. Signiﬁcant progress in this direction was achieved by the
design of serum-stable nucleic acid analogues and mimics
with improved target afﬁnity and low toxicity and by the
development of highly efﬁcient antisense strategies using
the cellular RNA interference (RNAi) pathway. The use of
RNAi has been found to be an efﬁcient silencing mechanism
based on double-stranded RNA molecules, particularly small
interfering RNAs (siRNAs), and the high potency of siRNAs
to suppress gene expression was demonstrated [for recent
reviews see (1–3)]. However, it has become clear that effect-
ively delivered and rationally targeted traditional gene silen-
cing molecules such as oligodeoxynucleotide analogues and
mimics can silence gene expression as efﬁciently as the best
siRNA molecules (4,5). Among earlier developed antisense
agents, locked nucleic acids (LNAs) (6,7), phosphorodiamid-
ate morpholino oligomers (MOs) (8) and peptide nucleic acids
(PNAs) (9) can be evaluated as the most promising molecules.
Charge-neutral DNA mimics, PNAs and MOs have been
developed as compounds, which are unaffected by cellular
nucleases and have strong RNA binding. In spite of high
afﬁnity towards DNA and RNA and stringent mismatch dis-
crimination, the antisense application of unmodiﬁed PNAs
is restricted by their inefﬁcient cell membrane translocation,
poor water-solubility and tendency to self-aggregation
(10,11). Nevertheless, promising results have been reported
in a range of systems exploited cell-penetrating peptides as
carriers for PNAs delivery (12). At their turn, MOs exhibit
high solubility in water despite their lack of charge, owing to
their strong polarity, but they have lower afﬁnity to nucleic
acids and mismatch discrimination ability than PNAs
(8,13,14).
For some years, we have studied PNA analogues, which
contain monomer units connected with phosphonate ester
bonds. A set of negatively charged PNA-like DNA mimics
was designed, and their properties were investigated (15–17).
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doi:10.1093/nar/gkl249Much of our interest has been focused on the preparation
of oligomers containing conformationally restricted
elements. Thus, hetero-oligomers consisting of alternating
phosphono-PNA monomers and PNA-like monomers
based on trans-4-hydroxy-L-proline (HypNA-pPNAs) were
designed (17,18). The evaluation of physico-chemical pro-
perties of this chimeric DNA mimic revealed that
HypNA-pPNA oligomers have excellent solubility in water
and at the same time preserve biological stability and high
hybridization characteristics of classical PNAs demonstrating
strong and speciﬁc binding to DNA and RNA targets (19,20).
The direct comparison of gene silencing efﬁciency of
HypNA-pPNAs with the efﬁciency of PNAs and MOs validate
this type of negatively charged mimics as an effective altern-
ative to PNAs and MOs for gene knockdown experiments
in vivo (21,22).
More recently, conformationally constrained chiral
phosphono-PNA analogues representing derivatives of trans-
4-hydroxy-N-acetyl-pyrrolidine-2-phosphonicacid(pHypNAs)
were prepared (23,24), and examination of their physico-
chemical and biological properties in comparison with natural
oligonucleotides, PNAs, MOs and HypNA-pPNA oligomers
was initiated. Herein we report the results obtained in the
investigation of properties of trans-L pHypNA oligomers in
terms of biological stability, ability to penetrate into living
cells and down-regulate gene expression in vitro and in vivo.
MATERIALS AND METHODS
Synthetic oligonucleotides and mimics
Synthesis of oligodeoxyribonucleotides was performed by the
standard solid-phase phosphoramidite method using mono-
mers purchased from Glen Research. Synthesis of oligoribo-
nucleotides was carried out by the phosphoramidite method
using 1-phenyl-1H-tetrazole-5-thiol as the activation agent as
described (25). MOs were purchased from Gene Tools. Chain
elongation in the automated solid phase synthesis of
HypNA-pPNA and pHypNA oligomers was carried out
using the properly protected dimer and monomer units,
respectively, by the phosphotriester method using
O-nucleophilic intramolecular catalysis according to the pre-
viously developed protocols (19,23). Fluorescein-labeled oli-
gomers were synthesized on the 30-ﬂuorescein CPG-support
(Glen Research). The removal of protective groups and isola-
tion of oligomers was performed as described earlier (19,23).
The identity of the oligomers obtained was conﬁrmed by mass
spectrometry (MALDI TOF).
Thermal denaturation experiments
Absorbance versus temperature curves of complexes formed
by oligomers with the corresponding DNA, or RNA, templates
were measured using an Ultrospec 2000 UV-VIS spectropho-
tometer (Pharmacia) equipped with a temperature control unit.
Solutions of each oligomer (3–5 mM) were mixed in 100 mM
NaCl/10 mM Tris–HCl (pH 7)/10 mM MgCl2 and heated at
95 Cfor2min. Themixturewasallowedtocool slowlybefore
data collection. The changes in absorbance were measured at
260 nm with a heating rate 0.5 C/min from 20 to 95 C. Melt-
ing temperatures (Tm) were taken to be the temperature of a
half-dissociation and were obtained from a plot of the deriv-
ative of 1/T versus absorbance.
RNA production and in vitro translation
The plasmid pSPFLuc containing the sequence coding ﬁreﬂy
luciferase was obtained from pSPluc+NF vector (Promega) by
the insertion between its EcoRI and XbaI restriction sites of a
synthetic poly-(A)30 region. The plasmid pRL-SV40 (Pro-
mega) coding Renilla luciferase and the plasmid pSPFLuc
were linearized by the action of BamHI and XhoI enzymes,
respectively, and puriﬁed on 1% agarose gel with the follow-
ing electro-elution from the excised gel bands. Each puriﬁed
plasmid (10 mg) was used as a template in 200 ml transcription
reactions. Renilla and ﬁreﬂy luciferase mRNAs were tran-
scribed using the RiboMax T7 and SP6 production systems
(Promega), respectively, following the manufacturer’s proto-
col. RNA transcripts were puriﬁed using mTRAP mRNA
isolation system (Active Motif), which utilizes biotinylated
homo-Thy HypNA-pPNA probe and Streptavidin-coated
magnetic beads, as described (26).
In vitro translation assays were performed using nuclease-
treated rabbit reticulocyte lysate (Promega) in 30 ml reaction
mixtures containing 25 ng of each mRNA to prime translation
reactions. Oligomers were added to mRNA in various concen-
trations prior to the addition of the lysate, without a pre-
hybridization step. After 60 min incubation at 30 C in the
presence, or absence, of the desired antisense oligomer, the
translation level of the Renilla and ﬁreﬂy RNAs was evaluated
by Dual-Luciferase Reporter Assay System (Promega) using
BD Monolight 3096 microplate luminometer. The effect of
antisense oligomers was evaluated by measuring the ratio
between Renilla and ﬁreﬂy luciferases. Each data point was
averaged over two replicates of three separate experiments.
Cellular uptake
In each experiment, twoidentical 24-well plates were prepared
with the Phoenix ecotropic packaging cell line derived from
293T cells (7 · 10
4 cells per well) and cultured at 37 C for
16–20 h in DMEM (PanEco) supplemented with 10% of fetal
bovine serum (FBS) purchased from Gibco-Life Technologies
andpenicillin-streptomycin(100U/mlofeach)withoutphenol
red. Then, 3 h before transfection the culture medium was
changed for DMEM/FBS without antibiotics. Fluorescently
labeled mimic oligomers were prepared in 2 mM concentration
in DMEM, subsequently diluted and added to the cells. For
cationic lipids mediated delivery, complexes of oligomers
with Lipofectamine-2000 (Invitrogen) were formed by the
pre-incubation with lipofectamine (2 ml) in 250 mlo f
DMEM for 30 min. After 4–20 h incubation of cells with
oligomers under the standard growth conditions, cells were
washed with phosphate-buffered saline (PBS) with following
incubation in DMEM/10% FBS for 2–6 h. In some experi-
ments, oligomers were prepared in 100 mM chloroquine, or in
6m MC a C l 2, in DMEM, and added to the cells for incubation
with the following washing and incubation as before. On this
step, cells were analyzed by phase contrast and ﬂuorescence
microscopy, and images were taken with Olimpus CK40
inverted microscope by DP50 Olimpus CD camera. After
that, the medium was removed; the monolayer washed
3 times with 1 ml PBS, and 200 ml PBS was added to each
2248 Nucleic Acids Research, 2006, Vol. 34, No. 8well, cells scraped and suspended. The suspension from each
well was split in two 100 ml portions. One protion was used for
direct ﬂuorescence measurement on a Microplate ﬂuorymeter
FFM-01 (Cortec). Second portion was used for quantiﬁcation
of the cellular concentration of ﬂuorescently labeled mimics as
described (22).
Confocal microscopy
Phoenix Eco cells (10 · 10
3) were plated on a 4-well Lab-Tek
chambered cover-glass (Nunc) in DMEM/10%FBS and cul-
tured for 20 h. The medium was discarded and cells were
incubated for 16 h with 250 ml of 0.5 mM solution oligomer
in DMEM in the presence, or in the absence, of 100 mM
chloroquine, or 6 mM CaCl2, for 20 h. After two washes,
200 ml of DMEM (without phenol red) was added into the
wells for observation of living cells. The cells were subjected
tomicroscopicstudieswithoutﬁxationusingaLeicaLCSTCS
SP confocal system based on DMIRBE Leica inverted micro-
scope with a HCX APO CS 63.0X1.32 objective. The Argon
laser was used to excite ﬂuorescein at 488 nm, and a HQ 515/
30 ﬁlterwas used forobservation of the emission. The imaging
conditions were kept constant for the observation of the
different samples.
Inhibition of GFP expression in cells
The Phoenix Eco cells were maintained at <80% conﬂuence in
DMEM supplemented with 10% FBS and antibiotics. Cells
were seeded 24 h before treatment at 40% conﬂuence in
35 mm diameter culture dishes (5 · 10
5 cells per dish). Before
the transfection, growth media was removed and replaced with
2 ml of fresh media without antibiotics. Cells in a dish were
transfected by p2FP-RNAi dual-color vector (Evrogen) using
1 mg of the plasmid DNA and 2 ml of LFA per 2 ml of the
media. Immediately after this, an aliquot of the preliminary
prepared mixture of an antisense oligomer (10 mM) and LFA
(20 ml) in 1 ml of DMEM, which was incubated for 20 min in
the dark, was added to the cells to obtain the proper concen-
tration of the oligomer. At different time points after trans-
fection, growth media containing the transfection mixture was
replaced with fresh media containing serum and antibiotics,
and the cells were subjected to ﬂuorescent imaging. For
trypsination, cells were washed with PBS three times and
trypsinized for 10 min at 37 C following with the addition
of PBS to 2 ml. Fluorescent measurements of proteins pro-
duction in the cells were performed in 100 ml aliquots of the
cell suspension in the wells of the black polystyrene 96-well
plate (Costar) using the ﬂuorymeter with the corresponding
ﬁlters for registration of TurboGFP ﬂuorescence (lex 482nm;
lem538nm)orJRedﬂuorescence(lex546nm;lem607nm)and
accumulative time 1000 ms. Relative ﬂuorescence was calcu-
lated by dividing the mean ﬂuorescence of the oligomer-
treated sample by the mean ﬂuorescence of a control sample
without the treatment.
Embryos handling and microinjection of oligomers
All operations with Xenopus embryos were performed as
described (27). From 2 to 6 nl of 0.25 mM oligomer solution
in water was microinjected into the right dorsal blastomere of
2–4-cell stage embryos by Eppendorf FemtoJet microinjector.
For cell lineage labeling, the samples were mixed with Fluor-
esceine-Lysinated-Dextran amine (FLD) (Molecular Probes).
RESULTS AND DISCUSSION
Synthesis and hybridization properties of
pHypNA oligomers
With the aim in view to obtain molecules possessing increased
binding afﬁnity to nucleic acids, phosphono-PNA oligomers
(pPNAs) with N-(2-hydroxyethyl)-phosphono glycine, or
N-(2-aminoethyl)-phosphono glycine backbone were synthe-
sized using the solid phase technique based on the phospho-
triester oligonucleotide synthesis with the O-nucleophilic
intra-molecular catalysis (15). Using the same approach and
dimers as building blocks, chimeras composed of pPNA and
PNA monomers (PNA-pPNAs) and hetero-oligomers with
alternating pPNA and HypNA monomers (HypNA-pPNAs)
were obtained (16,17). A HypNA monomer structure is
based on trans-4-hydroxy-L-proline, and it represents con-
formationally constrained chiral PNA analogue, in which
the b-C atom of a hydroxyethyl unit and the a-C atom of a
glycine unit of the backbone are bridged by methylene group.
The HypNA-pPNA mimic was the most perspective and
demonstrated high water solubility in combination with strong
binding to complementary DNA and RNA strands and high
level of speciﬁcity. The melting temperatures of complexes
formed by HypNA-pPNAs with nucleic acid targets are very
close to those formed by classical PNAs (17,18).
HypNA-pPNA compounds were shown to be effective anti-
sense agents in experiments with cell cultures and living
organisms (21–24). However the necessity to use preliminary
prepared dimers as units for their chemical synthesis is incon-
venient and restricts their wide application in molecular
biology to some extent.
To continue our investigations, a novel type of DNA mim-
ics, pHypNA oligomers, totally constructed from the chiral
monomers derived from 4-hydroxyproline was recently
designed (18,23,24). The pHypNA molecule represents
conformationally constrained phosphono-PNA analogue
(Figure 1). Earlier, the inﬂuence of a pHypNA monomer
conﬁguration on hybridization properties of the corresponding
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Figure 1. General chemical structures of HypNA-pPNA and pHypNA DNA
mimics.
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active Thy-pHypNA monomers were synthesized as well as
oligomers totally constructed from monomers of the same
chiral type. The results obtained in the study of the binding
properties of these oligomers to complementary poly-dA and
poly-rA targets have shown that oligomers totally constructed
from pHypNA units of trans-L type exhibited the best hybrid-
izationcharacteristics,whichwere very close tothose ofPNAs
and HypNA-pPNAs (23,24). Moreover, like other negatively
charged PNA-analogues, pHypNAs demonstrated excellent
solubility in water. Later, the corresponding trans-L adenine-,
cytosine- and guanine-containing pHypNA monomers
were synthesized and used for the solid-phase synthesis of
trans-L pHypNA oligomers with mixed nucleobase sequences.
As well as for other phosphonate-containing mimics, the
synthesis of these oligomers was carried out by the phospho-
triester method with O-nucleophilic intra-molecular catalysis.
Procedures for the synthesis, deblocking and isolation of
the mimics were essentially as described (19,20). From
the ultraviolet-titration data and the mobility shift analysis
in polyacrylamide gel electrophoresis, it was concluded
that, similar to PNAs and other PNA-like mimics, pHypNA
homo-pyrimidine sequences form triple helixes with comple-
mentary DNA (or RNA) targets, whereas oligomers with
mixed nucleobase sequences form duplexes (23,24). It should
be noted that the mobility of mimic oligomers and their com-
plexes with the complementary oligonucleotides in a native
polyacrylamide gel electrophoresis was different from the
mobility of the iso-sequential natural oligonucleotides and
their duplexes (Supplementary Figure 1).
Earlier, itwas shown thatthevaluesofmelting temperatures
(Tm) of 16–18 bp pHypNA/DNA(RNA) duplexes are practic-
ally equivalent to those of duplexes formed by HypNA-pPNA
oligomers (21,23,24). The examination of a salt concentration
inﬂuence on melting temperatures of duplexes and triplexes
formed by pHypNA mimics with the complementary DNA
and RNA targets revealed that, similar to classic PNAs and
HypNA-pPNAs, the stability of their complexes with nucleic
acid targets are not dependent on ionic strength, and the
decrease of a salt concentration has practically no effect on
the stability of duplexes and triplexes formed by these mimics
(23,24). The evaluation of the discrimination ability of
pHypNA mimics in assays based on the hybridization tech-
nique revealed their high potential as bio-molecular probes
(17,24). The hybridization of these oligomers with DNA
and RNA targets occurred in a sequence speciﬁc manner,
and the formation of complexes between mimic probes and
non-complementary targets was notdetected.Theintroduction
of one mismatch in the center of a 16–18mer sequence gave
a drop of 12–20 C in the melting temperature of a duplex
depending on base mismatch position and the sequence
(23,24). Some results on the investigation of hybridization
ability and binding selectivity of the oligomers used in this
study are shown in Table 1. As it can be seen from the table,
the melting temperatures of duplexes formed by pHypNA
oligomers with the RNA targets are higher than those formed
by natural oligodeoxyribonucleotides. The introduction of two
separately situated mismatches into the sequence of mimic
oligomers leads to a signiﬁcant destabilization of their com-
plexes with the targets and gives a drop in Tm of 26–29 C for
pHypNA/RNA duplexes and 37–39 C for pHypNA/DNA
duplexes.
Biological stability of pHypNAs
The ideal antisense molecule should not only effectively
recognize a target, but also be stable in biological ﬂuids. It
was shown that classical PNAs are stable to the action of
proteases, and they have a half-live in serum of  48 h
(28). Earlier, we have shown that phosphonate-containing
analogues of PNAs are highly stable to the action of nucleases
(24). Although natural nucleobases are the components of
pHypNA molecules, these compounds do not contain phos-
phodiester bonds found in the backbone of natural oligonuc-
leotides. This is probably the reason why nucleases do not
recognize this type of molecules as substrates (Supplementary,
Figure 2). Based on the data that the major process of the
oligonucleotide degradation occurs outside of the cell in
the extra-cellular medium (29), we additionally examined the
susceptibility of pHypNAs to the degradation in DMEM
containing 10% FBS. As PNA-related mimics do not interact
with intercalating dyes, particularly with ethidium bromide
(23), we used in this study the ﬂuorescently labeled oligomers
in conjunction with a mobility shift analysis in denaturing
conditions (Figure 2). The results obtained have shown that
>60% of the initial amount of the pHypNA oligomer was still
stable after 48 h incubation, and the half-life of the pHypNAs
can be estimated as  72 h. At the same time, >50% of the
control natural 30-ﬂuorescein labeled oligodeoxyribo-
nucleotide was cleaved after 12 h incubation at the same
conditions, and it was practically fully degraded in 24 h. Sim-
ilar stability of pHypNAs was observed in cytoplasmic and
nuclear cell extracts (data not shown). Consistent with these
observations, we concluded that the high stability of these
mimics can allow them to preserve their action in cells for
a prolonged period of time after a single administration.
Silencing in a Cell-Free Translation System
Theinitial evaluation ofpHypNAsantisensepropertiesagainst
their targets has been performed in an in vitro translation assay
with puriﬁed mRNA transcripts containing the coding
sequences for ﬁreﬂy (FLuc) and Renilla (RLuc) luciferases.
The pHypNA probe complementary to the start codon region
of the ﬁreﬂy luciferase coding sequence and the corresponding
HypNA-pPNA probe were synthesized, and the relative efﬁ-
ciency of these oligomers against the same transcript was
tested. After the incubation in a cell-free translation system
containing FLuc and RLuc mRNAs, the relative effect of
antisense oligomers was evaluated by measuring the ratio
between ﬁreﬂy and Renilla luciferase production in the pres-
ence and in the absence of oligomers. It was found that both
types of oligomers exhibited strong antisense effect at
50–200 nM concentrations with up to 85% reduction of the
FLuc production (Figure 3). The inhibition was dose-
dependent and still observed at 5 nM of oligomers. Practically
no reduction of RLuc activity was seen in any case (data not
shown). The control oligomers with two mismatches and oli-
gomers with scrambled sequences had no inhibitory effect
under the same conditions.
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In contrast to natural oligonucleotides and their phosphoro-
thioate analogues and similar to PNAs, negatively charged
PNA-like mimics do not activate RNase-H upon binding to
RNA (22,24), and their ability to affect mRNAs is more likely
to be directly associated with steric hindrances. Therefore
signiﬁcant amounts of such antisense oligomers must be
delivered into the cells to block translation or redirect splicing,
and an efﬁcient delivery is very important to observe strong
gene knockdown effect. Usually, antisense oligonucleotides
and their analogues (e.g. phosphorothioates) are effectively
delivered into eukaryotic laboratory cell lines via cationic
liposome complexation (30). PNAs being uncharged
molecules cannot directly give complexes with cationic lipo-
somes, and their delivery via this route is possible using PNA–
lipid conjugates, PNA–DNA hybrids or duplexes formed by
PNAs with the complementary oligonucleotides (31). Also, a
number of studies exploited PNA conjugates with cell-
penetrating peptides (12,32) or other carriers such as
9-aminoacridine (31), but in some cases these systems deliver
PNAs mainly to the lysosomal compartments of eukaryotic
cells and not efﬁciently to the cytosolic and nuclear compart-
ments, where they should act as antisense agents (12,33).
Nevertheless, the results have been reported on the signiﬁcant
enhancement of classical PNAs antisense effect in the pres-
ence of calcium ions as well as lysosomotropic reagent chlor-
oquine, presumably by facilitating endosomal release of
antisense compounds (12,33,34).
In previous studies with HypNA-pPNA oligomers, it was
shown that free HypNA-pPNAs are able to penetrate into
cultured HS-68 and HeLa cells and distribute in the cytoplasm
(22,23). The addition of cationic lipids, or a non-covalent
peptide-based delivery system Pep-2, improves their delivery
into living cells. Confocal microscopy evidence was obtained
that in this case HypNA-pPNAs are localized mainly in the
cytoplasm with some staining in nucleus (22).
Delivery of a ﬂuorescein-labeled pHypNA oligomer into
eukaryotic cells was tested in several formats, particularly
as a free oligomer, its duplex with the complementary
oligodeoxyribonucleotide (CT-ODN) and those in combina-
tion with Lipofectamine-2000 (LFA). In control experiments,
the Flu-labeled HypNA-pPNA oligomer was added to cells
either free, orin the complex with CT-ODN.Transfection with
the ﬂuorescein-labeled pHypNA oligomer, or with its duplex
with CT-ODN, in the presence of LFA resulted in a high level
of ﬂuorescence in treated cells after 4 h already. Maximum
Table 1. Sequences and hybridization properties of oligonucleotides and DNA mimics used in this study
Oligomer sequence (target)
a Complementary oligonucleotide
a ODN
Tm,  C( Da;D)
b
HypNA-pPNA
Tm ,  C(Da;D)
b
pHypNA
Tm ,  C( Da;D)
b
TCACTCAACACTCAC-Flu d(GTGAGTGTTGAGTGA) 57 58 55
TGGCGTCGGTGACCAT (FLuc) d(ATGGTCACCGACGCCA) 64 65 67
TGGCGTCGGTGACCAT (FLuc) r(AUGGUCACCGACGCCA) 56 73 72
TGGaGTCGGcGACCAT (FLuc) d(ATGGTCACCGACGCCA)  25 ( 36)  26 ( 39)  28 ( 39)
TGGaGTCGGcGACCAT (FLuc) r(AUGGUCACCGACGCCA) 32 ( 24) 48 ( 25) 45 ( 27)
GCTCTCGTCGCTCTCCAT (GFP) d(CATGGAGAGCGACGAGAGCGGC) 69 65 63
GCTCTCGTCGCTCTCCAT (GFP) r(CAUGGAGAGCGACGAGAGC)dTT 68 76 75
GCTCTaGTCGCTaTCCAT (GFP) d(CATGGAGAGCGACGAGAGCGGC) 34 ( 35) 31 ( 34)  26 ( 37)
GCTCTaGTCGCTaTCCAT (GFP) r(CAUGGAGAGCGACGAGAGC)dTT 49 ( 19) 51 ( 25) 49 ( 26)
r(GCUCUCGUCGCUCUCCAUG)dTT (GFP) r(CAUGGAGAGCGACGAGAGC)dTT 86 - -
TGCGCTTTCTTTTGTCTG (Ras-dva) r(CAGACAAAAGAAAGCGCA) 60 64 67
TGCtCTTTCTTcTGTCTG (Ras-dva) r(CAGACAAAAGAAAGCGCA) 35 ( 25) 43 ( 21) 38 (M29)
aThesequenceisshownfrom50to30endofanoligonucleotide,orfrompseudo-50topseudo-30endofamimicoligomer.Lowercasebaserepresentsamismatchposition.
bThe value in brackets shows the difference between the melting temperature of duplexes formed by the oligomers with matched and mismatched sequences with
complementary targets.
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Figure2. Analysisofthestabilityofthefluorescein-labeledpHypNAoligomer
(Flu-1) by the electrophoresis in a 15% polyacrylamide gel in denaturing con-
ditions. The oligomer (5 mM) was incubated at 37 C in 500 ml of DMEM/10%
FBS.Aliquots(20ml)weretakenateach24handfrozenat 20 Cuntilanalysis
by electrophoresis. (A) The image shows probes of the mimic oligomer taken
after48h(1),72h(2),120h(3)and0h(4)incubation;thevisualizationwasin
UV-light at 365 nm. (B) The comparison of the stability of the fluorescein-
labeled pHypNA oligomer and the control 30-fluorescein-labeled oligodeoxy-
ribonucleotideofthe samesequence.Densitometriccalculationsofthe amount
of full-length oligomer were done using UVP Bio-Imaging system and Lab-
Works imaging software.
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with free pHypNA oligomer, or with that in combination with
CT-ODN, resulted in much lower intracellular ﬂuorescence
(Figure 4A). Similar results were obtained with ﬂuorescein-
labeled HypNA-pPNA oligomer. Counter staining with prop-
idium iodide indicated that the mimics did not show any
cellular toxicity (data not shown).
To obtain a detailed determination of the intracellular
localization of the pHypNAs, we examined the ability of a
pHypNA oligomer to penetrate into eukaryotic cells by live-
cell confocal microscopy. In these experiments, the Flu-
pHypNA oligomer, or its duplex with the complementary
oligodeoxyribonucleotide, were incubated with living cells
in the presence of LFA. Confocal microscopy showed that
in all cases pHypNA oligomer appeared to be evenly distrib-
uted in the cytoplasm with preferential staining of the nucleus,
and the addition of lysosomotropic reagent chloroquine,
or calcium ions, had no inﬂuence on the distribution.
Figure 4B shows some examples of typical confocal micro-
scopy images with a signiﬁcant and uniform ﬂuorescence in
the cytosol and nucleus both in the presence and in the absence
of chloroquine and calcium ions. Moreover, co-administration
of chloroquine in 100 mM concentration had a negative inﬂu-
ence on the cell viability, which was found to be 80–85%
related to the viability of untreated cells and cells treated
with CaCl2 (data not shown).
Gene silencing in cell culture
The experiments on down-regulation of protein production in
living cultured cells by hydroxyproline-based mimic oli-
gomers were initiated several years ago with HypNA-pPNA
mimics. Antisense HypNA-pPNA 16–18mer oligomers
demonstrated efﬁcient and speciﬁc inhibition of green ﬂuor-
escent protein (GFP) production in Escherichia coli cells and
AChE-R production in rat brain cell culture in 0.5 mM con-
centration (35). The down-regulation of the levels of cyclin
B1, a protein essential for cell cycle progression, was demon-
strated for HypNA-pPNAs in 50–100 nM concentrations in
HeLa cells, human ﬁbroblasts HS 68 and 293 cells (22). Their
antisense effect was analyzed in comparison with the effect of
classical PNAs and phosphorothioate oligonucleotides and
estimated as in 8.5-fold and 25-fold higher than in the case
of PNA oligomer and phosphorothioate oligonucleotide,
respectively (22). In recent reports, HypNA-pPNA oligomers
were successfully used for the investigation of the mechanism
of Mallory body formation in the liver cells of chronic liver
diseases (36) as well as for down-regulation of various genes
in zebraﬁsh (21,37,38).
To compare the in vivo antisense effect of pHypNA oli-
gomers with that of corresponding HypNA-pPNA oligomers
and double-stranded siRNA (dsRNA), a dual-reporter system
based on a novel mammalian expression vector p2FP-RNAi
was used. This vector was recently designed for RNAi studies
FLuc mRNA
5’-…CCAUGGUCACCGACGCCAAAAACAUAAAGAAAGG… -3’
Pseudo-5’- TGGCGTCGGTGACCAT antisense (AS)
Pseudo-5’- TGGaGTCGGcGACCAT mismatched (MM)
Pseudo-5’- ACACTTACACTTACAC scrambled (SC)
Figure 3. Dose-dependent inhibition of firefly luciferase translation in vitro by the mimic antisense oligomers targeted against the translational start site of FLuc
mRNA.(A)SequencesofHypNA-pPNAandpHypNAoligomersdesignedtotarget theFLucmRNA;(B)Analysisoffireflyluciferasetranslationinhibitionbythe
oligomers. Firefly luciferase activity was calculated relative to the activity in the absence of any oligomer and normalized respect to Renilla luciferase production.
2252 Nucleic Acids Research, 2006, Vol. 34, No. 8and encoded two ﬂuorescent reporter proteins, TurboGFP and
JRed-Neo. The genes for both proteins are under the control of
an immediate early promoter of cytomegalovirus, and their
codon usage is optimized for high expression in mammalian
cells. TurboGFP is an improved variant of the green ﬂuores-
cent protein CopGFP cloned from copepoda Pontellina
plumata (39). It reveals bright green ﬂuorescence, which
can be clearly detected in cells within 4–8 h after transfection,
and does not form aggregates in long-term cultures. Moreover,
fast maturation in eukaryotic cells improves the ability to
visualize gene expression and protein localization at early
stages of biological processes. JRed is a novel red ﬂuorescent
protein obtained by mutagenesis of Anthomedusae jellyﬁsh
chromoprotein (39). After the transfection into eukaryotic
cells, JRed function serves as a positive transfection marker,
while TurboGFP stands as an indicator of gene silencing
efﬁciency. In the presence of a functional antisense compound
directed against TurboGFP, its expression is knocking down,
whereas JRed expression remains unmodiﬁed. Thus, the
increasing red/green ﬂuorescence intensity ratio compared
with control experiment indicates successful performance of
antisense agent.
To test a potential of pHypNAs as TurboGFP gene knock-
down agents, the antisense pHypNA and HypNA-pPNA oli-
gomers directed against the start codon region of TurboGFP
mRNA as well as control mismatched and scrambled oli-
gomers were used (Figure 5). Phoenix Eco cells were trans-
fected with p2FP-RNAi vector mixed with the oligomers in
the presence of LFA. Treatment with antisense oligomers
produced a dose-dependent decrease of green ﬂuorescence
in the cells compared with the untreated control, whilst
practically no reduction in JRed activity was seen in any
case. Mismatched and scrambled oligomers were inactive in
the assays. A signiﬁcant level of reduction of TurboGFP was
seen at 0.5–1 mM concentration of antisense oligomers. The
comparison of mimic effectiveness revealed that pHypNA
oligomer was even more effective than the corresponding
HypNA-pPNA oligomer in the gene knockdown tests
(Figure 5). Both antisense oligomers were still able to suppress
the target gene expression at a concentration of 100 nM
that is in accordance with the data published earlier for
HypNA-pPNAs (22). As a variant, antisense oligomers
were delivered into the cells as duplexes with the complement-
ary oligodeoxyribonucleotide. In the presence of LFA, the use
of duplexes had some positive effect on the antisense activity
of oligomers, probably owing to faster delivery into the cells
in comparison with single-stranded mimics. The addition of
6m MC a
2+ into a culture medium had a positive inﬂuence on
the antisense activity of oligomers, and in this case the sufﬁ-
cient level of TurboGFP reduction can be also achieved with-
out the addition of LFA to the antisense oligomer before the
cell transfection (data not shown). The comparison of anti-
sense effect of the pHypNA oligomer with that of the synthetic
dsRNA directed against TurboGFP revealed that 0.5 mM
mimic oligomer was practically as active as 0.2 mM dsRNA
(Figure 5). Cell viability was >90% for all experiments with
mimics (data not shown). It should be noted that dsRNA used
in this study was iso-sequential to antisense pHypNA and
HypNA-pPNA oligomers. It was directed against the start
codon region of TurboGFP, and its target site on mRNA
was not optimized.
Furthermore, the time course for the suppression of Tur-
boGFP expression by the oligo-mimics was investigated. An
effective silencing of the target gene for up to 3 days was
observed for both types of antisense mimics (data not
shown). Maximal inhibition level of this protein was found
to be at 24–48 h post-transfection for pHypNA and
HypNA-pPNA antisense mimics, whereas for dsRNA it was
estimated as 24 h.
Gene knockdown in a living model organism
Thenextstepofthe pHypNAs evaluationasantisenseagentsis
the examination of their potency for down regulation of genes
in living organisms. In previous years, MOs were successfully
utilized in the living models, particularly Danio rerio
(zebraﬁsh) and Xenopus laevis, for genome-wide, sequence-
based, reverse genetic screens during embryonic development.
Negatively charged HypNA-pPNA oligomers were evaluated
as an alternative to MOs for inhibition of gene expression in
zebraﬁshembryos,anditwasshownthattheyare effective and
speciﬁc in vivo translational inhibitors in over a range of
developmental stages (37,38). It was observed that
HypNA-pPNA 18mer displayed comparable potency to
25mer MOs as gene knockdown agents and demonstrated
higher sequence speciﬁcity and greater mismatch stringency
than MOs. Another key advantage of HypNA-pPNAs for gene
knockdown studies is the lack of nonspeciﬁc effects, and doses
of HypNA-pPNA, which are high enough to produce strong
loss-of-function phenotypes, produced few or no non-speciﬁc
effects.
The gene knockdown efﬁciency of pHypNAs in comparison
with MOs and HypNA-pPNAs was estimated in Xenopus
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Figure 4. Cellular uptake and intracellular distribution of the fluorescein-
labeled mimicoligomers (TCACTCAACACTCAC-Flu). (A) Fluorescentana-
lysisofthedeliveryofoligomers(1mM)intoPhoenixEcocellsperformed20h
after the treatment under various delivery conditions: in the presence, or in the
absence, of LFA, 6 mM CaCl2, and 100 mM chloroquine (ClQ). (B) Confocal
microscopy images of the pHypNA oligomer uptake after 20 h incubated with
unfixed Phoenix Eco cells in the presence of: LFA (1); LFA/6mM Ca
2+ (2);
CT-ODN/ LFA (3) and LFA/100 mM ClQ (4).
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Figure 5. Analysis of the reduction of TurboGFPlevels by antisense mimic oligomers in PhoenixEco cells transfected with p2FP-RNAi vector. Co-transfection of
oligomers was performed in the presence of LFA. The cells transformed with the vector alone were analyzed as controls. (A) Sequences of oligomers designed to
target the translational start site of the TurboGFP mRNA. (B) Analysis of green and red fluorescence intensity of the cells treated with 0.5 mM oligomers, or with
0.2 mM dsRNA, after 24 h. The average data of three separate experiments are shown. (C) Fluorescent microscopy images of the cells transfected with p2FP-RNAi
andtreatedwith0.5mMmimicoligomersamplesfor16and24h.Panelsshowexamplesofcellstreatedwith0.2mMdsRNA(a);mismatchedpHypNAoligomer(b);
duplex of antisense pHypNA oligomer with CT-ODN (c); duplex of antisense HypNA-pPNA oligomer with CT-ODN (d); antisense pHypNA oligomer (e) and
antisense HypNA-pPNA oligomer (f). Panel (g) shows cells untreated with oligomers. (D) Effect of the antisense oligomer concentration on the TurboGFP
production in cells. Fluorescence was measured 24 h after the transfection. Average data points from three independent experiments are shown.
2254 Nucleic Acids Research, 2006, Vol. 34, No. 8embryos. Recently, the gene for a novel Ras-like GTPase
Ras-dva was identiﬁed, and it was reported that Ras-dva
and its homologues in other species constitute a novel family
of Ras-like small GTPases (27). This protein is expressed
during X.laevis neurulation in a very restricted area surround-
ing the anterior margin of the neural plate. The sequences of
antisense oligomers were designed against the mRNA
50-untranslated region, which is conservative in both
pseudo-alleles of the X.laevis Ras-dva. The down-regulation
of its functioning by microinjecting MO antisense 25mer into
early embryos resulted in severe head development abnormal-
ities on the injected side of 40–62% of the developing
tadpoles. These include a reduction of the forebrain, olfactory
pits, otic vesicles, branchial arches and malformations of the
head cartilages. Similar abnormalities were observed for
60–85% tadpoles after microinjecting antisense pHypNA, or
HypNA-pPNA, oligomers (Figure 6). The speciﬁcity of the
effects obtained was conﬁrmed by the fact that neither head
nor trunk abnormalities were observed when the control oli-
gomerswith mismatched and scrambled sequences were injec-
ted. These results show that the negatively charged pHypNA
mimics can act as speciﬁc antisense inhibitors of gene function
in living model organisms. The experiments on the examina-
tion of antisense properties of pHypNA oligomers in zebraﬁsh
embryos are currently in progress.
CONCLUSIONS
The major aim of this study was to investigate the properties
and evaluate the potency of a novel type of antisense com-
pounds, trans-L pHypNAs, representing negatively charged
conformationally constrained phosphono-PNA analogues.
These DNA mimics combine high hybridization and discrim-
ination characteristics with good water solubility and biolo-
gical stability as well as the ability to penetrate cell
Ras-dva mRNA
5’…AACGCAGACAAAAGAAAGCGCAAUCUCACCAUGUCUGUA…3’
Morpholino oligomers
antisense Pseudo-5’ GTGAGATTGCGCTTTCTTTTGTCGT
mismatched Pseudo-5’ GTGAcATTGCtCTTTCTTTTGTgGt
pHypNA and HypNA-pPNA oligomers
Pseudo-5’ TGCGCTTTCTTTTGTCGT antisense
Pseudo-5’ TGCtCTTTCTTcTGTCGT mismatched
Figure 6. Images of Xenopus tadpole heads as seen from the dorsal side and the sequences of MO, pHypNA and HypNA-pPNA oligomers used in Ras-dva
mRNA translation inhibitory assays. The injection of antisense oligomers results in severe abnormalities of the head structure. The side of injection is shown by
red arrow. (A) A control tadpole head; (B, C and D) heads of tadpoles developed from the embryos microinjected with the antisense MO, pHypNA and
HypNA-pPNA oligomers, respectively; (E and F) heads of tadpoles developed from the embryos microinjected with the mismatched pHypNA and HypNA-pPNA
oligomers.
Nucleic Acids Research, 2006, Vol. 34, No. 8 2255membranes. The efﬁcacy of pHypNAs as antisense agents was
demonstrated in a cell-free system, living cells and a living
model organism. These compounds demonstrated high anti-
sense activityinacell-freesystem,and thedegreeofinhibition
of gene expression by pHypNAs in cultured cells was higher
than that with HypNA-pPNAs. The results obtained in gene
knockdown experiments in Xenopus embryos characterize
pHypNAs as useful tools and a valuable alternative to MOs
and HypNA-pPNAs for reverse genetic studies. Also, it is
important to note that pHypNA oligomers can be easily syn-
thesized from 4 monomers, and therefore they are more
accessible compounds than HypNA-pPNAs, the synthesis of
which needs the availability of 16 dimers. Attributes described
above are important with respect to a potential therapeutic
utilization of the pHypNA compounds as they promote
gene silencing in living cells for a prolonged period of
time. Based on the antisense potency of pHypNAs and
their superiority comparing the earlier proposed by us
HypNA-pPNAs, we can conclude that pHypNA mimics are
attractive compounds for broad applications in life science
research and drug discovery.
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